News

Farber, with the creation of a new cancer hospital, is moving forward after the completion of the regulatory process.
Beth Israel Deaconess Medical Center fosters a culture of inclusion, wellness, and community — where every patient, trainee, and staff member feels valued.
BIDMC's PGY1 Pharmacy Residency Program continues the development and training of future clinical pharmacists. See our current preceptors and rotations.
BIDMC's Internal Medicine Residents are trained to provide high quality medical care. Meet our 2022-2023 residents.
Learn more about the symptoms, care and treatment of Crohn's disease. This is not meant to be an exhaustive review on the topic, but an introduction to a complex condition with answers to some of the ...
BOSTON – As part of its ongoing commitment to exploring leading-edge technology to further enhance patient care, Beth Israel Deaconess Medical Center (BIDMC) will participate in an early access ...
Boston – Affecting more than 7 million adults in the United States, gout is characterized by a sudden onset of pain, swelling and stiffness in the joints and caused by the formation of urate crystal ...
One-Third of Clinical Trial Participants Who Received No Vaccine Reported Systemic Adverse Advents Like Headache and Fatigue BOSTON – The placebo effect is the well-known phenomenon of a person's ...
BOSTON – Rural Americans are less likely to have health insurance, have less access to healthcare services for urgent conditions and are more likely to encounter lower quality care than their urban ...
Companion study suggests initial infection with SARS-CoV-2 protects against re-infection following repeat exposure to the virus Boston – With nearly 5 million confirmed cases globally and more than ...
Researchers evaluated efficacy of stress management practices with randomized controlled trial Boston – University students are uniquely vulnerable to stress, both psychological and physiological. In ...
BOSTON – Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published ...